Results

Total Results: 1,583 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
    December 14, 2012 - Given what we know about traditional markers, particularly tumor grade, it is almost certain that patients … Response is generally reserved for metastatic disease where actual tumor measurements are possible. … #5 KI Background P 2 . . . patients with MSI-H tumors are excluded. Add the word tumors. … Public Agendia Background P.3 Tumor Heterogeneity (comment) Please note that the impact of tumor heterogeneity … issue of ASCO Post published a brief summary of data from this study that were presented at ASCO's GI Cancers
  2. effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-decision-aid.pdf
    March 01, 2016 - Is Lung Cancer Screening Right for Me? What is lung cancer? … These cells can form a tumor and can spread to other parts of the body. … » Lung cancer is the leading cause of cancer death in the United States. … lung cancer: 3 lung cancer deaths will be prevented. 18 people will die of lung cancer. 21 people … Lung cancer screening is done to find lung cancer before it has spread.
  3. effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/03.html
    June 08, 2018 - Home Consumers Clinically Localized Prostate Cancer Prostate Cancer Archived … This short video will tell you about the prostate gland, where it is located, and what happens when a tumor … A small tissue mass is then shown inside the prostate (a tumor). … The tumor grows to push against the outer wall of the prostate, forcing the wall to bulge against the … The tumor then expands outside the prostate, covering parts of the rectum.
  4. effectivehealthcare.ahrq.gov/health-topics/male-breast-cancer
  5. effectivehealthcare.ahrq.gov/health-topics/prostate-cancer-screening
  6. effectivehealthcare.ahrq.gov/health-topics/cervical-cancer-screening
  7. effectivehealthcare.ahrq.gov/health-topics/bile-duct-cancer
  8. effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research
    December 23, 2014 - Structured Abstract Background Many health decisions about screening and treatment for cancers involve … It is unclear whether the effectiveness of decision aids for decisions related to cancers differs by … people's average risk of cancer or by the content and format of the decision aid. … We predefined three population groups of interest based on risk or presence of cancer (average cancer … risk, high cancer risk, early cancer).
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-draft-report.pdf
    October 31, 2023 - all gastrointestinal malignancies.1 However, its incidence has risen steadily by two to three percent … carcinoma of the anus (SCCA) is by far the most common histology, accounting for over 90 percent of anal malignancies … proton beam radiotherapy, and de-escalation of radiation dosing for appropriate stages.6 More advanced tumors … myelosuppression, gastrointestinal toxicity, such as diarrhea, vomiting, and bowel obstruction, secondary malignancy … Efficacy of capecitabine versus 5- fluorouracil in colorectal and gastric cancers: a meta-analysis of
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
    March 25, 2012 - “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR carcinoma)) AND … OR ((ovarian OR breast OR colorectal OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND (‘neoplasm’/exp OR … ‘neoplasms’/exp OR ‘cancer’/exp OR ‘carcinoma’/exp)) AND [humans]/lim AND [english]/lim AND [embase] … /lim #60 #17 AND #59 #61 #56 AND #60 Ovarian Cancer #61 ‘ovarian’/exp AND (‘neoplasm’/exp OR
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
    October 27, 2015 - nonmuscle invasive bladder cancer. … On one end of the spectrum are patients with low grade noninvasive tumors that rarely develop tumors … implies that cystoscopy is the gold standard for the identification and surveillance of urothelial malignancies … related to the pre-test probability of a urothelial malignancy as AHRQ has done for the progression … How often will a subsequent work up in the setting of persistent hematuria reveal a urothelial malignancy
  12. effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
    February 24, 2016 - and malignant disease (many studies included only tumors confirmed to be cancer). … tumors in the cohort. … applicability to clinical decision making and the vast majority of patients presenting with renal cortical neoplasms … The main point is that larger tumors are associated with malignancy, and that the OR of 1.3 gives a … who proceeds to surgery as patient or tumor characteristics (i.e. male sex, larger tumors) influence
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
    December 01, 2011 - “Tumor volume” is probably the wrong search term. … We did not include % of cores in tumor volume. … incidence after the introduction of PSA-based screening is among low-stage tumors. … in lieu of locally advanced cancers. … integral dose results in detectable clinical differences----presumably in side effects and second malignancies-over
  14. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
    February 01, 2006 - Layout 1 Background Breast cancer is the second most common malignancy in women. … If a noninvasive diagnostic test were available that could accurately exclude malignancy, many women … , each would miss some cancers. … PET scan, about 924 women would have avoided an unnecessary biopsy, but 76 women would have missed cancers … negative US, about 950 women would have avoided an unnecessary biopsy, but 50 women would have missed cancers
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
    March 11, 2010 - Introduction p. 11 some of these tumor types aren’t “basic” We have removed the word “basic”. … Diagnoses of malignancy on core-needle biopsy that cannot be confirmed on open biopsy are assumed to … Most such tumors would probably be classified as “invasive” in most of the studies. … Results The wide range of prevalence of malignancy from 15% to 68.9% suggests to me that the 15% is … Results p. 50 the evidence seems to suggest a risk of malignancy of much less than 8%.
  16. effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship
    June 24, 2020 - Disparities and Barriers for Pediatric Cancer Survivorship Care Timeline June 24, 2020 … June 24, 2020 Research Protocol Disparities and Barriers for Pediatric Cancer … March 01, 2021 Technical Brief Disparities and Barriers to Pediatric Cancer
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-survivor-care-transition_research-protocol.pdf
    March 27, 2013 - Search "Survivors"[Mesh] OR survivorship OR survivor Filters: Humans; English 498,795 #10 Search "Neoplasms … Search 23257892[uid] 1 #2 Search "Survivors"[Mesh] OR survivorship OR survivor 771137 #3 Search "Neoplasms … #12 Search (#1 AND #9) 0 #13 Search (#1 AND #9) Schema: all 0 Search (("Survivors"[MAJR] AND "Neoplasms … late effects of treatment, second cancers, and poor quality of life, to provide a knowledge base regarding … optimal followup care and surveillance of cancers, and to optimize health after cancer treatment.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_disposition-comments.pdf
    May 24, 2013 - They vary by liver function, performance status, and tumor stage. … Patients with low tumor burden (typically < 3 tumors all less than 3 cm) are offered percutaneous/operative … If they have more advanced disease (intermediate-staged HCC) with multifocal tumors or large tumors … Childs C patients typically are not candidates for cancer directed therapies with rare exception. … Childs C patients typically are not candidates for cancer directed therapies with rare exception.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
    January 01, 2020 - incidence, advanced breast cancer, breast cancer mortality, and all-cause mortality, quality-of-life … Breast cancer screening 4. Cervical cancer screening 5. Colorectal cancer screening 6. … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
    November 12, 2013 - (breast, colon, lung and prostate), and according to high prevalence versus rare cancers. … modified to the correct terminology for CINAHL, PsycINFO, EMBASE, and any other databases searched: ("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous OR hypertrophy … and after”[tiab] or interrupted time*[tiab] or time serie*[tiab] or intervention*[tiab]))) AND (("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous)) Filters:Publication

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: